| Product Code: ETC8922794 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, North Macedonia continued to rely on imports of blood plasma derivatives, with key suppliers including Germany, Switzerland, Netherlands, Italy, and Japan. The High Herfindahl-Hirschman Index (HHI) indicates a concentrated market. Despite a slight decline in growth rate from 2023 to 2024, the compound annual growth rate (CAGR) of 15.65% over the period 2020-24 demonstrates a strong overall upward trend in the importation of these critical medical products. This data suggests that North Macedonia`s demand for blood plasma derivatives remains robust, with potential opportunities for further market expansion and diversification in the future.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Republic of Macedonia Blood Plasma Derivative Market Overview |
3.1 Republic of Macedonia Country Macro Economic Indicators |
3.2 Republic of Macedonia Blood Plasma Derivative Market Revenues & Volume, 2021 & 2031F |
3.3 Republic of Macedonia Blood Plasma Derivative Market - Industry Life Cycle |
3.4 Republic of Macedonia Blood Plasma Derivative Market - Porter's Five Forces |
3.5 Republic of Macedonia Blood Plasma Derivative Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Republic of Macedonia Blood Plasma Derivative Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Republic of Macedonia Blood Plasma Derivative Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Republic of Macedonia Blood Plasma Derivative Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for blood plasma derivatives in the healthcare sector for treating various diseases and medical conditions |
4.2.2 Growing prevalence of chronic diseases and blood disorders in the population, leading to higher consumption of blood plasma derivatives |
4.2.3 Technological advancements in the production and purification processes of blood plasma derivatives |
4.3 Market Restraints |
4.3.1 Strict regulatory requirements and quality standards for the production and distribution of blood plasma derivatives |
4.3.2 Limited availability of donors and plasma collection centers, affecting the supply of raw materials for manufacturing blood plasma derivatives |
5 Republic of Macedonia Blood Plasma Derivative Market Trends |
6 Republic of Macedonia Blood Plasma Derivative Market, By Types |
6.1 Republic of Macedonia Blood Plasma Derivative Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Republic of Macedonia Blood Plasma Derivative Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Republic of Macedonia Blood Plasma Derivative Market Revenues & Volume, By Albumin, 2021- 2031F |
6.1.4 Republic of Macedonia Blood Plasma Derivative Market Revenues & Volume, By Factor VII, 2021- 2031F |
6.1.5 Republic of Macedonia Blood Plasma Derivative Market Revenues & Volume, By Factor IX concentrate, 2021- 2031F |
6.1.6 Republic of Macedonia Blood Plasma Derivative Market Revenues & Volume, By Anti-coagulation factor, 2021- 2031F |
6.1.7 Republic of Macedonia Blood Plasma Derivative Market Revenues & Volume, By Rh immunoglobulin, 2021- 2031F |
6.1.8 Republic of Macedonia Blood Plasma Derivative Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Republic of Macedonia Blood Plasma Derivative Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Republic of Macedonia Blood Plasma Derivative Market Revenues & Volume, By Immunodeficiency Diseases, 2021- 2031F |
6.2.3 Republic of Macedonia Blood Plasma Derivative Market Revenues & Volume, By Bleeding Disorders, 2021- 2031F |
6.2.4 Republic of Macedonia Blood Plasma Derivative Market Revenues & Volume, By Liver Conditions, 2021- 2031F |
6.2.5 Republic of Macedonia Blood Plasma Derivative Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Republic of Macedonia Blood Plasma Derivative Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Republic of Macedonia Blood Plasma Derivative Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Republic of Macedonia Blood Plasma Derivative Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.4 Republic of Macedonia Blood Plasma Derivative Market Revenues & Volume, By Transfusion Centers, 2021- 2031F |
7 Republic of Macedonia Blood Plasma Derivative Market Import-Export Trade Statistics |
7.1 Republic of Macedonia Blood Plasma Derivative Market Export to Major Countries |
7.2 Republic of Macedonia Blood Plasma Derivative Market Imports from Major Countries |
8 Republic of Macedonia Blood Plasma Derivative Market Key Performance Indicators |
8.1 Average selling price (ASP) of blood plasma derivatives in the market |
8.2 Number of approved applications for new blood plasma derivative products |
9 Republic of Macedonia Blood Plasma Derivative Market - Opportunity Assessment |
9.1 Republic of Macedonia Blood Plasma Derivative Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Republic of Macedonia Blood Plasma Derivative Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Republic of Macedonia Blood Plasma Derivative Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Republic of Macedonia Blood Plasma Derivative Market - Competitive Landscape |
10.1 Republic of Macedonia Blood Plasma Derivative Market Revenue Share, By Companies, 2024 |
10.2 Republic of Macedonia Blood Plasma Derivative Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |